Upregulation of Lhx8 increase VAChT expression and ACh release in neuronal cell line SHSY5Y

被引:6
作者
Li, Haoming [1 ]
Jin, Guohua [1 ,2 ]
Zhu, Peipei [3 ]
Zou, Linqing [1 ,2 ]
Shi, Jinhong [1 ,2 ]
Yi, Xin [1 ,2 ]
Zhang, Xinhua [1 ]
Tian, Meiling [1 ]
Qin, Jianbing [1 ]
机构
[1] Nantong Univ, Coll Med, Jiangsu Key Lab Neuroregenerat, Dept Human Anat, Nantong 226001, Jiangsu, Peoples R China
[2] Soochow Univ, Sch Med, Dept Human Anat & Histoembryol, Suzhou 215123, Peoples R China
[3] Shanghai Changzheng Hosp, Dept Pathol, Shanghai 200003, Peoples R China
基金
中国国家自然科学基金;
关键词
Lhx8; ChAT; VAChT; ACh; SHSY5Y; VESICULAR ACETYLCHOLINE TRANSPORTER; LIM-HOMEOBOX GENE; CHOLINE-ACETYLTRANSFERASE; RETINOIC ACID; NEUROTROPHIC FACTOR; L3/LHX8; DIFFERENTIATION;
D O I
10.1016/j.neulet.2013.11.047
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Lhx8 is a transcription factor for cholinergic differentiation. Our previous experiments found upregulation of Lhx8 promoted cholinergic neuronal differentiation of hippocampal neural stem/progenitor cells or hippocampal newborn neurons in vitro. However, the role of Lhx8 in VAChT expression and ACh release is still less understood. In this report, we transfected Lhx8 cDNA into neuronal cell line SHSY5Y by lentiviral vectors to acquire the cells which stably expressed high level of Lhx8. Using this cell model, we provided experimental evidence that increasing Lhx8 upregulated the expression of ChAT and VAChT, and also increased the ACh release in culture medium. We suggested that Lhx8 overexpression is a useful strategy to increase the release of ACh and maybe of therapeutic value to neurodegenerative diseases. (c) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:184 / 188
页数:5
相关论文
共 21 条
  • [1] Allen SJ, 2011, CURR NEUROPHARMACOL, V9, P559, DOI 10.2174/157015911798376190
  • [2] Arvidsson U, 1997, J COMP NEUROL, V378, P454
  • [3] BERRARD S, 1995, J NEUROCHEM, V65, P939
  • [4] COORDINATED UP-REGULATION OF CHOLINE-ACETYLTRANSFERASE AND VESICULAR ACETYLCHOLINE TRANSPORTER GENE-EXPRESSION BY THE RETINOIC ACID RECEPTOR-ALPHA, CAMP, AND LEUKEMIA INHIBITORY FACTOR CILIARY NEUROTROPHIC FACTOR SIGNALING PATHWAYS IN A MURINE SEPTAL CELL-LINE
    BERSE, B
    BLUSZTAJN, JK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (38) : 22101 - 22104
  • [5] The cholinergic system and hippocampal plasticity
    Drever, Benjamin D.
    Riedel, Gernot
    Platt, Bettina
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2011, 221 (02) : 505 - 514
  • [6] Expression of trkB in human neuroblastoma in relation to MYCN expression and retinoic acid treatment
    Edsjö, A
    Lavenius, E
    Nilsson, H
    Hoehner, JC
    Simonsson, P
    Culp, LA
    Martinsson, T
    Larsson, C
    Påhlman, S
    [J]. LABORATORY INVESTIGATION, 2003, 83 (06) : 813 - 823
  • [7] Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells
    Encinas, M
    Iglesias, M
    Liu, YH
    Wang, HY
    Muhaisen, A
    Ceña, V
    Gallego, C
    Comella, JX
    [J]. JOURNAL OF NEUROCHEMISTRY, 2000, 75 (03) : 991 - 1003
  • [8] LIM homeodomain transcription factor-dependent specification of bipotential MGE progenitors into cholinergic and GABAergic striatal interneurons
    Fragkouli, Apostolia
    van Wijk, Nicole Verhey
    Lopes, Rita
    Kessaris, Nicoletta
    Pachnis, Vassilis
    [J]. DEVELOPMENT, 2009, 136 (22): : 3841 - 3851
  • [9] Cholinergic activity correlates with reserve proxies in Alzheimer's disease
    Garibotto, Valentina
    Tettamanti, Marco
    Marcone, Alessandra
    Florea, Ioana
    Panzacchi, Andrea
    Moresco, Rosamaria
    Virta, Jere R.
    Rinne, Juha
    Cappa, Stefano F.
    Perani, Daniela
    [J]. NEUROBIOLOGY OF AGING, 2013, 34 (11) : 2694.e13 - 2694.e18
  • [10] Regulatory logic of neuronal diversity: Terminal selector genes and selector motifs
    Hobert, Oliver
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (51) : 20067 - 20071